U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390617) titled 'A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma' on Jan. 21.
Brief Summary: The purpose of this study is to see how results of nerve tests change in people with urothelial cancer who receive treatment with enfortumab vedotin (EV)
Study Start Date: Jan. 20
Study Type: OBSERVATIONAL
Condition:
Neuropathy
Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Intervention:
OTHER: Non-therapeutic Nerve Conduction Studies
Non-invasive nerve conduction studies (NCS) offer an objective, quantitative approach to assess peripheral nerve function, particularly in sensory fibers, which are most common...